NDVAX Fees and Costs — MFS New Discovery Value Fund, Class A
Data updated: 2026-07-27
The net expense ratio is 1.22%: a 0.83% management fee, a 0.25% 12b-1 fee plus 0.15% other expenses, less a 0.01% fee waiver. This share class carries a maximum front-end sales load of 5.75% and a deferred sales charge of up to 1.00%. In fiscal 2026 the fund paid $1.3M in broker commissions, 0.0459% of average net assets, and portfolio turnover was 47%.
NDVAX Fees and Expenses
Annual operating expenses and sales charges of NDVAX. Prospectus, as of February 28, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.83% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.15% |
| Gross expense ratio | 1.23% |
| Fee waiver | −0.01% |
| Net expense ratio | 1.22% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 1.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
NDVAX Costs Over Time
On $10,000 invested in NDVAX, assuming 5% a year before costs, total costs come to $1,476 over 5 years, cutting the return by 2.55% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $673 | $575 | $575 |
| Fund expenses (net expense ratio 1.22%) | $121 | $376 | $650 |
| Trading costs (broker commissions) | $5 | $14 | $24 |
| Lost growth on money paid in costs | $29 | $110 | $227 |
| Total costs | $827 | $1,075 | $1,476 |
| Value after costs | $9,673 | $10,501 | $11,287 |
| Impact on return, per year | 8.27% | 3.36% | 2.55% |
NDVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending February 28, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0459%
- Total broker commissions: $1.3M
- Bought from dealers (principal trades, not a cost): $140.0M
- Portfolio turnover (prospectus): 47%
- Securities on loan, average value: $18.5M
- Net income from securities lending: $248K (0.009% of average net assets)
NDVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BofA Securities, Inc. | $204K | 19.58% |
| Jefferies LLC | $203K | 19.45% |
| J.P. Morgan Securities LLC | $122K | 11.71% |
| JonesTrading Institutional Services LLC | $93K | 8.90% |
| UBS Securities LLC | $88K | 8.45% |
| Morgan Stanley & Co. LLC | $82K | 7.84% |
| BMO Capital Markets Corp. | $74K | 7.06% |
| National Financial Services LLC | $64K | 6.09% |
| Goldman Sachs & Co. LLC | $60K | 5.73% |
| TD Securities (USA) LLC | $54K | 5.20% |
NDVAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $32.4M | 23.15% |
| Jefferies LLC | $28.7M | 20.53% |
| J.P. Morgan Securities LLC | $17.2M | 12.28% |
| RBC Capital Markets, LLC | $14.6M | 10.39% |
| Goldman Sachs & Co. LLC | $13.7M | 9.75% |
| Barclays Capital Inc. | $13.0M | 9.31% |
| BNY Capital Markets, LLC | $11.0M | 7.86% |
| BofA Securities, Inc. | $9.4M | 6.73% |
MFS New Discovery Value Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| NDVVX | Class R6 | 0.87% | none |
| NDVIX | Class I | 0.97% | none |
| NDVUX | Class R4 | 0.97% | none |
| NDVAX | Class A | 1.22% | 5.75% |
| NDVTX | Class R3 | 1.22% | none |
| NDVSX | Class R2 | 1.47% | none |
| NDVBX | Class B | 1.97% | none |
| NDVCX | Class C | 1.97% | none |
| NDVRX | Class R1 | 1.97% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.